novel coronavirus pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Affiliated Hospital of Changchun University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Suspected, mild, normal and severe cases diagnosed in accordance with the diagnosis and treatment scheme for pneumonia of novel coronavirus infection (trial version 5); 2. Aged >= 18 years; 3. Patients who voluntarily participate in the study and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Known to be allergic to the ingredients contained in the research medication, or patients with allergies; (2) Unwilling to cooperate with the information collector; (3) Patients with mental illness, or cognitive impairment; (4) Women who are breastfeeding or pregnant, or who have a positive urine pregnancy test, or who do not agree to contraception within 3 months of participating in the test; (5) Other patients that the investigator considers unsuitable to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Critically ill patients (%);Mortality Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cure rate of clinical symptoms;Imaging absorption of pneumonia;The incidence of complications;Intensive Care Time;Inhospital time;Total cost of treatment;Time for clinical symptom to disappear; | — |
Countries
China
Contacts
Public ContactWang Tan
Affiliated Hospital of Changchun University of traditional Chinese Medicine
Outcome results
None listed